Streetbeat News

Products Services

BOTZ

NVDA

SMH

VTI

XLK

NVIDIA Corp's (NVDA) shares surged over 15% following a quarterly earnings report that exceeded expectations, highlighting its strategic position in the AI technology sector. This success not only boosted NVIDIA's market cap significantly but also positively impacted related tech companies and ETFs. Companies like Meta Platforms Inc (META), Alphabet Inc (GOOG, GOOGL), Microsoft Corp (MSFT), Amazon.com Inc (AMZN), Taiwan Semiconductor Mfg. Co. Ltd. (TSM), Super Micro Computer Inc (SMCI), Advanced Micro Devices, Inc. (AMD), and others saw varying degrees of stock price movements. ETFs with significant NVIDIA holdings, such as Technology Select Sector SPDR Fund (XLK), Global X Robotics and Artificial Intelligence ETF (BOTZ), VanEck Semiconductor ETF (SMH), and Vanguard Total Stock Market Index Fund ETF (VTI), also experienced gains.

Portfolio Pulse from Natan Ponieman

February 22, 2024 | 9:43 pm

COLD

CP

Americold Realty Trust (NYSE:COLD) announced plans to develop its first cold storage facility on the Canadian Pacific Kansas City (CPKC) rail network in Kansas City, Missouri, marking a strategic collaboration between COLD and CPKC (TSX:CP) (NYSE:CP). The $127 million facility aims to connect key U.S. Midwest and Mexico markets, supporting CPKC's MMX service for more efficient goods transport. The project, expected to create nearly 190 jobs, underscores Missouri's strategic value and aims to strengthen North American supply chains.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 9:43 pm

RKT

Rocket Companies, Inc. (NYSE:RKT) reported Q4 financial results surpassing analyst expectations with adjusted earnings of zero cents per share, beating the forecasted 4 cent loss, and a 29.58% increase in adjusted sales to $885 million. The company highlighted its use of AI and automation in improving operational efficiency and forecasts Q1 adjusted revenue between $925 million and $1.075 billion. Shares rose 5.65% after-hours.

Portfolio Pulse from Erica Kollmann

February 22, 2024 | 9:34 pm

LGND

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced its partner Eisai Co., Ltd. received approval in Japan for an injection formulation of the antiepileptic drug Fycompa, formulated with Ligand's Captisol technology. This marks the 16th Captisol-enabled product approved worldwide. Ligand is entitled to royalties from sales of this new formulation. Fycompa, a first-in-class AED, targets glutamate activity at AMPA receptors to reduce seizures. It is approved in over 75 countries for various forms of epilepsy.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 9:29 pm

NCBDY

WBD

Bandai Namco's Elden Ring has reached 23 million sales, marking a significant increase from the previous year. The game's success is highlighted alongside the announcement of a new DLC, Shadow of the Erdtree, set for release in June. Comparatively, Warner Bros. Discovery Inc's Hogwarts Legacy has sold 24 million copies in 2023. Future expansions for Elden Ring are hinted at but not confirmed.

Portfolio Pulse from Franca Quarneti

February 22, 2024 | 9:16 pm

TBIO

Telesis Bio has been granted a European patent (EUR Patent #3503915) for 'Genetically Engineered Vibrio Natriegens (Host Organism For Cloning And Manipulating DNA)'. This patent represents a significant advancement in the field of genetic engineering, potentially enhancing Telesis Bio's capabilities in DNA manipulation and cloning using the fast-growing bacterium Vibrio natriegens.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 8:57 pm

BTCUSD

ETHUSD

MATICUSD

Reddit has disclosed in an SEC filing that it has invested part of its excess cash reserves in Bitcoin and Ether. Additionally, the company has acquired Ether and Matic through sales of certain virtual goods, a practice it may continue in the future.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 8:35 pm

T

AT&T announced that it has successfully restored wireless service to all customers affected by a recent service disruption, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 8:15 pm

COGT

Cogent Biosciences' stock price increased following the announcement of positive Part 1b data from its SUMMIT trial evaluating bezuclastinib.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 7:52 pm

SARK

SQ

TARK

Block, Inc (NYSE:SQ) is experiencing a surge over 5% ahead of its Q4 earnings, following a Q3 earnings beat. Analysts predict Q4 EPS of 59 cents on $5.699 billion revenue. Wedbush upgraded Block's rating to Outperform with a price target of $90. For diversification, investors might consider AXS 2X Innovation ETF (NASDAQ:TARK) and AXS Short Innovation Daily ETF (NASDAQ:SARK), related to ARK Innovation ETF's performance, which includes Block. Technical analysis shows Block trading neutrally with potential for both bullish and bearish reactions post-earnings.

Portfolio Pulse from Melanie Schaffer

February 22, 2024 | 7:47 pm